Dr. Reddy’s (NYSE: RDY) director Alpna Seth submits baseline Form 3 ownership

Rhea-AI Filing Summary

DR REDDYS LABORATORIES LTD director Alpna Seth filed an initial Form 3, which identifies her as a reporting person for the company. The filing shows no reported transactions or derivative positions and serves as a baseline disclosure of her status under insider reporting rules.

Key Terms

Form 3, reporting person, beneficial ownership

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"which identifies her as a reporting person for the company"

beneficial ownership financial

"initial beneficial ownership statement, not a trade report"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Seth Alpna

(Last) (First) (Middle)

485, EDGEWOOD ROAD

(Street)

SAN MATEO CALIFORNIA 94402

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
12/18/2025

3. Issuer Name and Ticker or Trading Symbol
DR REDDYS LABORATORIES LTD [ RDY ]

3a. Foreign Trading Symbol
[DRREDDY&500124]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ ALPNA SETH	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the RDY Form 3 filed by Alpna Seth show?

The Form 3 for DR REDDYS LABORATORIES LTD (RDY) identifies Alpna Seth as a director and reporting person. It reports no transactions or derivative positions, serving as an initial baseline disclosure of insider status under SEC ownership reporting rules.

Are there any stock purchases or sales in the RDY Form 3?

No, the RDY Form 3 for Alpna Seth shows zero reported purchases, sales, or other transactions. It is strictly an initial beneficial ownership statement, with transaction-related share counts all reported as zero in the summary data.

Does the RDY Form 3 show any derivative securities for Alpna Seth?

The Form 3 derivative summary for RDY lists no derivative holdings or transactions for Alpna Seth. Derivative-related counts, including exercises and derivative transactions, are all zero, indicating no options, warrants, or similar instruments disclosed in this filing excerpt.

What is the role of Alpna Seth at DR REDDYS LABORATORIES LTD?

The Form 3 identifies Alpna Seth as a director of DR REDDYS LABORATORIES LTD. She is not flagged as an officer or ten percent owner in this filing, which focuses on her status as a board-level reporting person under SEC insider disclosure rules.

Why is there a Form 3 for RDY if no transactions are reported?

Form 3 is an initial beneficial ownership statement, not a trade report. For RDY, Alpna Seth’s Form 3 establishes her as a reporting insider. Future transactions, if any, would typically be reported on subsequent Forms 4 or 5 rather than this baseline filing.